Oncternal Therapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Oncternal Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -131 %, a 73.8% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2023 was -83.6 %, a 47.5% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2022 was -56.7 %, a 88.2% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Return On Assets for 2021 was -30.1 %, a 21.8% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -83.6 -26.9 -47.5% Jan 1, 2023 Dec 31, 2023
2022 -56.7 -26.6 -88.2% Jan 1, 2022 Dec 31, 2022
2021 -30.1 +8.38 +21.8% Jan 1, 2021 Dec 31, 2021
2020 -38.5 +97.8 +71.8% Jan 1, 2020 Dec 31, 2020
2019 -136 -118 -647% Jan 1, 2019 Dec 31, 2019
2018 -18.2 +72.2 +79.8% Jan 1, 2018 Dec 31, 2018
2017 -90.4 -10.7 -13.4% Jan 1, 2017 Dec 31, 2017
2016 -79.7 -32.2 -67.8% Jan 1, 2016 Dec 31, 2016
2015 -47.5 +92.5 +66.1% Jan 1, 2015 Dec 31, 2015
2014 -140 +4.84 +3.34% Jan 1, 2014 Dec 31, 2014
2013 -145 -103 -243% Jan 1, 2013 Dec 31, 2013
2012 -42.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.